EVOK - Evoke Pharma Q2 GAAP loss per share narrows revenue up August, 10 2022 04:23 PM Evoke Pharma Inc. Evoke Pharma press release ( NASDAQ: EVOK ): Q2 GAAP EPS of -$0.71 (vs. -$0.85 Y/Y). Revenue of $0.46M (+91.7% Y/Y). For further details see: Evoke Pharma Q2 GAAP loss per share narrows, revenue up